T1	NC 0 5	Mujer
#1	Norm T1	mujer NCFS000
T2	SP 6 8	de
#2	Norm T2	de SPS00
T3	Z 9 11	52
#3	Norm T3	52 Z
T4	NC 12 16	años
#4	Norm T4	año NCMP000
T5	SP 17 20	con
#5	Norm T5	con SPS00
T6	NC 21 23	AR
#6	Norm T6	AR NC00000
T7	AQ 24 36	seropositiva
#7	Norm T7	seropositivo AQ0FS0
T8	AQ 37 44	erosiva
#8	Norm T8	erosivo AQ0FS0
T9	Fc 44 45	,
#9	Norm T9	, Fc
T10	NC 46 53	títulos
#10	Norm T10	título NCMP000
T11	AQ 54 59	altos
#11	Norm T11	alto AQ0MP0
T12	SP 60 62	de
#12	Norm T12	de SPS00
T13	NC 63 69	factor
#13	Norm T13	factor NCMS000
T14	AQ 70 80	reumatoide
#14	Norm T14	reumatoide AQ0CS0
T15	CC 81 82	y
#15	Norm T15	y CC
T16	NC 83 94	anticuerpos
#16	Norm T16	anticuerpo NCMP000
T17	NC 95 106	antipéptido
#17	Norm T17	antipéptido NCMS000
T18	AQ 107 114	cíclico
#18	Norm T18	cíclico AQ0MS0
T19	VM 115 126	citrulinado
#19	Norm T19	citrulinar VMP00SM
T20	Fpa 127 128	(
#20	Norm T20	( Fpa
T21	NC 128 136	anti-CCP
#21	Norm T21	anticcp NCMS000
T22	Fpt 136 137	)
#22	Norm T22	) Fpt
T23	SP 138 140	de
#23	Norm T23	de SPS00
T24	Z 141 143	12
#24	Norm T24	12 Z
T25	NC 144 148	años
#25	Norm T25	año NCMP000
T26	SP 149 151	de
#26	Norm T26	de SPS00
T27	NC 152 161	evolución
#27	Norm T27	evolución NCFS000
T28	Fc 161 162	,
#28	Norm T28	, Fc
T29	SP 163 166	con
#29	Norm T29	con SPS00
T30	NC 167 172	fallo
#30	Norm T30	fallo NCMS000
T31	AQ 173 183	secundario
#31	Norm T31	secundario AQ0MS0
T32	SP 184 185	a
#32	Norm T32	a SPS00
T33	NC 186 196	infliximab
#33	Norm T33	infliximab NC00000
T34	CC 197 198	y
#34	Norm T34	y CC
T35	NC 199 209	adalimumab
#35	Norm T35	adalimumab NCCS000
T36	Fp 209 210	.
#36	Norm T36	. Fp
T37	VM 211 219	Presenta
#37	Norm T37	presentar VMIP3S0
T38	NC 220 223	ojo
#38	Norm T38	ojo NCMS000
T39	AQ 224 228	rojo
#39	Norm T39	rojo AQ0MS0
T40	Fc 228 229	,
#40	Norm T40	, Fc
T41	NC 230 235	dolor
#41	Norm T41	dolor NCMS000
T42	CC 236 237	y
#42	Norm T42	y CC
T43	NC 238 247	fotofobia
#43	Norm T43	fotofobia NCFS000
T44	Fp 247 248	.
#44	Norm T44	. Fp
T45	NC 249 260	Exploración
#45	Norm T45	exploración NCFS000
T46	Fd 260 261	:
#46	Norm T46	: Fd
T47	VM 262 272	infiltrado
#47	Norm T47	infiltrar VMP00SM
T48	AQ 273 280	corneal
#48	Norm T48	corneal AQ0CS0
T49	NC 281 291	periférico
#49	Norm T49	periférico NCMS000
T50	SP 292 294	en
#50	Norm T50	en SPS00
T51	NC 295 303	semiluna
#51	Norm T51	semiluna NCFS000
T52	VM 304 312	asociado
#52	Norm T52	asociar VMP00SM
T53	SP 313 314	a
#53	Norm T53	a SPS00
T54	NC 315 325	escleritis
#54	Norm T54	escleritis NCFN000
T55	Fp 325 326	.
#55	Norm T55	. Fp
T56	NC 327 334	Cultivo
#56	Norm T56	cultivo NCMS000
T57	SP 335 338	del
#57	Norm T57	de+el SPS00+DA0MS0
T58	NC 339 346	raspado
#58	Norm T58	raspado NCMS000
T59	AQ 347 354	corneal
#59	Norm T59	corneal AQ0CS0
T60	AQ 355 363	negativo
#60	Norm T60	negativo AQ0MS0
T61	Fp 363 364	.
#61	Norm T61	. Fp
T62	VM 365 374	Iniciamos
#62	Norm T62	iniciar VMIP1P0
T63	NC 375 386	tratamiento
#63	Norm T63	tratamiento NCMS000
T64	SP 387 390	con
#64	Norm T64	con SPS00
T65	NC 391 401	prednisona
#65	Norm T65	prednisona NCFS000
T66	Z 402 403	1
#66	Norm T66	1 Z
T67	NC 403 405	mg
#67	Norm T67	mg NC00000
T68	Fh 405 406	/
#68	Norm T68	/ Fh
T69	NC 406 408	kg
#69	Norm T69	kg NC00000
T70	Fh 408 409	/
#70	Norm T70	/ Fh
T71	NC 409 412	día
#71	Norm T71	día NCMS000
T72	NC 413 416	vía
#72	Norm T72	vía NCFS000
T73	AQ 417 421	oral
#73	Norm T73	oral AQ0CS0
T74	CC 422 423	y
#74	Norm T74	y CC
T75	VM 424 433	decidimos
#75	Norm T75	decidir VMIS1P0
T76	NC 434 440	cambio
#76	Norm T76	cambio NCMS000
T77	SP 441 443	de
#77	Norm T77	de SPS00
T78	NC 444 449	diana
#78	Norm T78	diana NCFS000
T79	AQ 450 461	terapéutica
#79	Norm T79	terapéutico AQ0FS0
T80	SP 462 463	a
#80	Norm T80	a SPS00
T81	NC 464 473	rituximab
#81	Norm T81	rituximab NCMS000
T82	SP 474 475	a
#82	Norm T82	a SPS00
T83	NC 476 481	dosis
#83	Norm T83	dosis NCFN000
T84	AQ 482 490	habitual
#84	Norm T84	habitual AQ0CS0
T85	SP 491 493	en
#85	Norm T85	en SPS00
T86	NC 494 496	AR
#86	Norm T86	AR NC00000
T87	SP 497 500	con
#87	Norm T87	con SPS00
T88	NC 501 512	metotrexato
#88	Norm T88	metotrexato NCMS000
T89	Z 513 515	25
#89	Norm T89	25 Z
T90	NC 515 517	mg
#90	Norm T90	mg NC00000
T91	Fh 517 518	/
#91	Norm T91	/ Fh
T92	NC 518 524	semana
#92	Norm T92	semana NCFS000
T93	Fp 524 525	.
#93	Norm T93	. Fp
T94	SP 526 530	Tras
#94	Norm T94	tras SPS00
T95	DA 531 533	el
#95	Norm T95	el DA0MS0
T96	AO 534 540	primer
#96	Norm T96	1 AO0MS0
T97	NC 541 546	ciclo
#97	Norm T97	ciclo NCMS000
T98	SP 547 549	de
#98	Norm T98	de SPS00
T99	NC 550 559	rituximab
#99	Norm T99	rituximab NCMS000
T100	DA 560 562	la
#100	Norm T100	el DA0FS0
T101	NC 563 571	paciente
#101	Norm T101	paciente NCCS000
T102	VM 572 583	experimentó
#102	Norm T102	experimentar VMIS3S0
T103	AQ 584 588	gran
#103	Norm T103	gran AQ0CS0
T104	NC 589 596	mejoría
#104	Norm T104	mejoría NCFS000
T105	SP 597 600	con
#105	Norm T105	con SPS00
T106	NC 601 609	curación
#106	Norm T106	curación NCFS000
T107	SP 610 612	de
#107	Norm T107	de SPS00
T108	DA 613 615	la
#108	Norm T108	el DA0FS0
T109	NC 616 619	QUP
#109	Norm T109	QUP NC00000
T110	CC 620 621	y
#110	Norm T110	y CC
T111	VM 622 627	entró
#111	Norm T111	entrar VMIS3S0
T112	SP 628 630	en
#112	Norm T112	en SPS00
T113	NC 631 639	remisión
#113	Norm T113	remisión NCFS000
T114	AQ 640 647	clínica
#114	Norm T114	clínico AQ0FS0
T115	SP 648 650	de
#115	Norm T115	de SPS00
T116	DA 651 653	la
#116	Norm T116	el DA0FS0
T117	NC 654 656	AR
#117	Norm T117	AR NC00000
T118	Fp 656 657	.
#118	Norm T118	. Fp
T119	SP 658 659	A
#119	Norm T119	A SPS00
T120	DA 660 663	los
#120	Norm T120	el DA0MP0
T121	Z 664 666	10
#121	Norm T121	10 Z
T122	NC 667 672	meses
#122	Norm T122	mes NCMP000
T123	VM 673 681	apareció
#123	Norm T123	aparecer VMIS3S0
T124	SP 682 684	de
#124	Norm T124	de SPS00
T125	AQ 685 690	nuevo
#125	Norm T125	nuevo AQ0MS0
T126	DI 691 693	un
#126	Norm T126	uno DI0MS0
T127	VM 694 704	infiltrado
#127	Norm T127	infiltrar VMP00SM
T128	AQ 705 712	corneal
#128	Norm T128	corneal AQ0CS0
T129	CC 713 714	y
#129	Norm T129	y CC
T130	NC 715 725	escleritis
#130	Norm T130	escleritis NCFN000
T131	AQ 726 730	leve
#131	Norm T131	leve AQ0CS0
T132	CC 731 732	e
#132	Norm T132	y CC
T133	NC 733 739	inicio
#133	Norm T133	inicio NCMS000
T134	SP 740 742	de
#134	Norm T134	de SPS00
T135	NC 743 750	clínica
#135	Norm T135	clínica NCFS000
T136	AQ 751 760	articular
#136	Norm T136	articular AQ0CS0
T137	Fp 760 761	.
#137	Norm T137	. Fp
T138	VM 762 771	Decidimos
#138	Norm T138	decidir VMIS1P0
T139	VM 772 780	mantener
#139	Norm T139	mantener VMN0000
T140	NC 781 792	tratamiento
#140	Norm T140	tratamiento NCMS000
T141	SP 793 796	con
#141	Norm T141	con SPS00
T142	NC 797 806	rituximab
#142	Norm T142	rituximab NCMS000
T143	NC 807 811	i.v.
#143	Norm T143	i.v. NCFS000
T144	SP 812 814	en
#144	Norm T144	en SPS00
T145	NC 815 820	pauta
#145	Norm T145	pauta NCFS000
T146	SP 821 823	de
#146	Norm T146	de SPS00
T147	NC 824 826	AR
#147	Norm T147	AR NC00000
T148	DI 827 831	cada
#148	Norm T148	cada DI0CS0
T149	Z 832 833	8
#149	Norm T149	8 Z
T150	NC 834 839	meses
#150	Norm T150	mes NCMP000
T151	SP 840 843	con
#151	Norm T151	con SPS00
T152	AQ 844 848	buen
#152	Norm T152	bueno AQ0MS0
T153	NC 849 856	control
#153	Norm T153	control NCMS000
T154	AQ 857 864	clínico
#154	Norm T154	clínico AQ0MS0
T155	RG 865 870	tanto
#155	Norm T155	tanto RG
T156	SP 871 873	de
#156	Norm T156	de SPS00
T157	DP 874 876	su
#157	Norm T157	su DP3CS0
T158	NC 877 883	cuadro
#158	Norm T158	cuadro NCMS000
T159	AQ 884 890	ocular
#159	Norm T159	ocular AQ0CS0
T160	CS 891 895	como
#160	Norm T160	como CS
T161	AQ 896 905	sistémico
#161	Norm T161	sistémico AQ0MS0
T162	Fp 905 906	.
#162	Norm T162	. Fp
